Your Partner for Entering the Israeli Diabetes Technology Market
VALOOR connects international diabetes technology manufacturers with opportunities in Israel, combining historical glucose monitoring distribution experience with a renewed focus on building international partnerships.
Specialize in EU CE/MDR and Israeli AMAR filings


About Us
Experience. Focus. New Opportunities.
Since 1999
Established in 1999, VALOOR brings historical
experience in the distribution of glucose
monitoring products.
Today
Today, the company is focused exclusively on diabetes monitoring technologies and developing new partnerships with international manufacturers interested in the Israeli market.
Expertise
Regulatory Strength & Global Standards
With over 6 years of hands-on experience in Israeli and European (CE/MDR) regulatory compliance, VALOOR supports international medical device manufacturers on the pathway into the Israeli healthcare market.

Distribution Solutions
Building Opportunities in the Israeli Market
VALOOR seeks to work with international manufacturers looking for a local business partner to develop opportunities in Israel.
Current focus
VALOOR is currently seeking new international manufacturers and technology partners.

Market Development
Understanding the Israeli diabetes technology landscape to help manufacturers see where their technology can fit.

Distribution Partnership Development
Exploring distribution models with manufacturers that want a local business partner in Israel.

Business Development
Opening conversations and building relationships between international manufacturers and the Israeli market.

Market Access Coordination
Regulatory navigation and market access planning. We connect European regulatory frameworks (CE/MDR) with local Israeli Ministry of Health requirements to support the registration process.

Regulatory & Compliance Expertise
Support in navigating local regulatory requirements, drawing on 6+ years of experience in Israeli medical device registration (AMAR) and European CE/MDR standards.